SLS is a Stockholm regenerative-medicine clinic led by Dr. Torbjörn Ogéus. Agewell’s founder paid for exosome + PRF treatment over four visits for long-running tendon and joint pain and came away with a strong recommendation for execution and experience, while keeping the evidence caveat explicit.
This profile combines SLS published information with a first-person Agewell founder account. It is not a controlled clinical study, not medical advice, and not a substitute for a qualified physician.
“One of the few regenerative clinics we are willing to recommend from experience: simple room, premium clinical execution, serious specialist depth, and a founder-tested outcome that moved real function. The caveat is the category, not the clinic: exosomes and stem-cell-adjacent therapies remain a physician-led decision, not a checkout product.”
SLS, Stockholms Led- & Smärtspecialist, is based at Karlavägen 1 in Stockholm and positions itself around modern non-surgical pain treatment. Its published services include PRF/PRP, stem-cell treatment, HBOT, chiropractic and physiotherapy, and Arthrosamid for knee osteoarthritis.
The clinic presents Dr. Torbjörn Ogéus as a leading voice in regenerative medicine and says he has published more than 14 peer-reviewed studies in regenerative medicine and stem cells. SLS also publishes a research page covering PRF, SVF, exosomes, osteoarthritis and tendon-pain case series.
Agewell’s founder paid roughly 30,000 SEK for four visits combining exosomes and PRF for long-running tennis elbow, big-toe joint pain, running-limiting lower-limb pain and wrist pain. The premises were simple; the treatment experience felt premium, careful and specialist-led.
He reports meaningful improvement in pain, function and strength performance afterwards, including a sharp rebound in bench press that he attributes to better tendon and ligament recovery. That is a first-person outcome, not controlled proof, so we treat it as a strong experience signal rather than clinical evidence.
The fit is clearest for someone with chronic orthopedic pain who has already spent time and money on rehab, chiropractic work or conservative care and now wants a physician-led regenerative option with the uncertainty made explicit.
At about 30,000 SEK in the founder case, this is not cheap wellness. It can still be rationally priced if the alternative is years of unresolved pain, repeated appointments and lost training capacity.
Regenerative medicine is not a normal anti-aging purchase. Ask what product is being injected, where it came from, how sterility and storage are handled, whether imaging guidance is used, what adverse-event plan exists, and what rehab plan follows the procedure.
Regulatory status varies by country and product. As a safety benchmark, the US FDA warns that many regenerative products, including stem cells, stromal vascular fraction, ortho-biologics and exosomes, are marketed without approval for orthopedic conditions. That warning should not be ignored just because the clinic experience is strong.
Skip it if you expect guaranteed cartilage regrowth, a performance boost or biological reversal from a treatment package. Also skip if there is no diagnosis, no physician accountability, no clear consent discussion, or no tolerance for uncertain evidence.
Consider it if the problem is specific, chronic, orthopedic, costly in daily life, and you can evaluate it with a serious clinician instead of buying hope from a brochure.
Agewell’s founder reported meaningful improvement after SLS treatment over four visits combining exosomes and PRF for chronic tendon and joint pain. Treat that as a strong first-person outcome, not clinical proof; results depend on diagnosis, protocol, rehab and individual biology.
SLS positions exosomes as part of physician-led regenerative treatment for orthopedic and pain problems. The practical question is not just "do exosomes work?" but what product is used, how it is handled, whether imaging guidance is used, what consent says and what rehab plan follows.
SLS publishes starting prices for PRF, while the Agewell founder-reported exosome + PRF treatment cost about 30,000 SEK over four visits. Regenerative pricing is protocol-dependent, so confirm the current quote, number of sessions and what follow-up is included.
Not in the simple consumer sense. SLS has specialist depth and published research material, but stem-cell-adjacent and exosome therapies still require a physician-led risk discussion because regulatory status and evidence quality vary by treatment and indication.
SLS is most interesting for a specific, chronic orthopedic problem where conservative care has not solved the issue and the cost of doing nothing is real. It is not the right fit for someone buying vague anti-aging, guaranteed cartilage regrowth or a performance shortcut.
By David Persson · Updated 2026-06-12 · Pricing changes – confirm with the clinic · Corrections: hi@agewell.guide
The Agewell Briefing
One letter a week – what to buy, what to question, what to skip. No sponsors inside the letter, ever.
One email a week. Unsubscribe with one click.